Top Markets
#1 Nesa Nesa +337.53%
#2 EXOD EXOD +22.78%
#3 MetaDAO MetaDAO +17.01%
#4 Status Status +12.64%
#5 Wrapped NXM Wrapped NXM +7.23%
#6 Kinesis Silver Kinesis Silver +6.60%
#7 Venom Venom +5.81%
#8 Tornado Cash Tornado Cash +4.89%
#9 HOME HOME +4.80%
#10 Ontology Gas Ontology Gas +3.99%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
Rank in Stocks #19936
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Share Price
$5.22
Last synced: 2026-08-25
Market Cap
$146.14M
Change (1 day)
-1.35%
Change (1 year)
-32.08%
Country
BE
Trade Hyloris Pharmaceuticals S.A. (HYL)

Category

Healthcare
Stock price history for Hyloris Pharmaceuticals S.A. (HYL)
Highest end of day price: $5.35 on 2026-08-01

Lowest end of day price: $11.76 on 2020-06-01
Stock price history of Hyloris Pharmaceuticals S.A. from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -3.01%
2025 17.57%
2024 -54.17%
2023 -2.50%
2022 -29.03%
2021 58.84%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.65 -12.25%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH